Zhang Bi Xiang, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma (NCT05031949) | Zhang Bi Xiang, MD | 2021-10-30 |
Track Zhang Bi Xiang, MD automatically
Every clearance here is in the API, with alerts when new ones post.